These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 15081039)
1. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039 [TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity. de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides. Smaine FZ; Winum JY; Montero JL; Regainia Z; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2007 Sep; 17(18):5096-100. PubMed ID: 17646100 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides. Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII. Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design. Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety. Salmon AJ; Williams ML; Innocenti A; Vullo D; Supuran CT; Poulsen SA Bioorg Med Chem Lett; 2007 Sep; 17(18):5032-5. PubMed ID: 17681760 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895 [TBL] [Abstract][Full Text] [Related]
18. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335 [TBL] [Abstract][Full Text] [Related]
19. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. Turkmen H; Durgun M; Yilmaztekin S; Emul M; Innocenti A; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Jan; 15(2):367-72. PubMed ID: 15603956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]